A study analysing rate and reason of discontinuation and response of intravesical onabotulinum toxin A treatment in patients with symptomatic Overactive Bladder
Latest Information Update: 20 Jan 2021
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 22 Nov 2020 Results presented at the 50th Annual Meeting of the International Continence Society
- 22 Nov 2020 Results presented at the 50th Annual Meeting of the International Continence Society
- 20 Aug 2020 New trial record